National Analysis of the Requirements and Implementation of State Prescription Drug Price Transparency Laws
The Milbank Quarterly · 2025
DOI: 10.1111/1468-0009.70023 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Milbank Quarterly, 2025. Verfasst von Hannah Rahim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Law School. Hauptthemen laut MEDLINE: Prescription Drugs, Drug Costs, Drug Industry, Disclosure. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Policy Points A total of 21 states have passed drug price transparency laws with the goals of creating accountability around drug pricing and facilitating the development of policy solutions to address high prices. These laws vary in design but often require manufacturers to report the wholesale acquisition cost of drugs above a certain threshold for new drugs or of drugs that undergo a price increase above a certain margin, along with other data such as the manufacturer's costs. Initial findings suggest these laws may have contributed toward informing policymaking based on newly available public information but do not appear to have affected drug prices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harvard Law School.
- Harvard T.H. Chan School of Public Health.
- Program on Regulation, Therapeutics, and Law (PORTAL), Harvard University.
- Brigham and Women's Hospital, Harvard Medical School.
ORCID-Profile: Hannah Rahim, Aaron S Kesselheim
Zitieren
APA
Rahim, H., & Kesselheim, A. S. (2025). National Analysis of the Requirements and Implementation of State Prescription Drug Price Transparency Laws. The Milbank Quarterly. https://doi.org/10.1111/1468-0009.70023
Vancouver
Rahim H, Kesselheim AS. National Analysis of the Requirements and Implementation of State Prescription Drug Price Transparency Laws. The Milbank Quarterly. 2025. doi:10.1111/1468-0009.70023
BibTeX
@article{Rahim2025,
author = {Rahim, Hannah and Kesselheim, Aaron S},
title = {National Analysis of the Requirements and Implementation of State Prescription Drug Price Transparency Laws},
journal = {The Milbank Quarterly},
year = {2025},
doi = {10.1111/1468-0009.70023}
}
EUVIMED